Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statement Detail - Outstanding Securities Considered Anti-Dilutive (Details)

v3.22.2
Condensed Consolidated Financial Statement Detail - Outstanding Securities Considered Anti-Dilutive (Details) - shares
shares in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 5,898 5,385 5,822 5,326
Convertible preferred stock        
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 5,003 5,003 5,003 5,003
Stock Options        
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 889 377 813 318
Warrants for common stock        
Antidilutive Securities Excluded From Computation Of Earnings Per Share        
Antidilutive securities excluded from computation of net loss per share (in shares) 6 5 6 5